chr11-108159001-A-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002519.3(NPAT):​c.4225T>G​(p.Ser1409Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,454,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1409L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

NPAT
NM_002519.3 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.58

Publications

0 publications found
Variant links:
Genes affected
NPAT (HGNC:7896): (nuclear protein, coactivator of histone transcription) Enables protein C-terminus binding activity; transcription coactivator activity; and transcription corepressor activity. Involved in positive regulation of transcription by RNA polymerase II and regulation of transcription involved in G1/S transition of mitotic cell cycle. Located in Cajal body; Gemini of coiled bodies; and cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
NPAT Gene-Disease associations (from GenCC):
  • colorectal cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11256504).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPATNM_002519.3 linkc.4225T>G p.Ser1409Ala missense_variant Exon 18 of 18 ENST00000278612.9 NP_002510.2 Q14207
NPATNM_001321307.1 linkc.4246T>G p.Ser1416Ala missense_variant Exon 18 of 18 NP_001308236.1
NPATXM_011542854.3 linkc.4252T>G p.Ser1418Ala missense_variant Exon 18 of 18 XP_011541156.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPATENST00000278612.9 linkc.4225T>G p.Ser1409Ala missense_variant Exon 18 of 18 1 NM_002519.3 ENSP00000278612.8 Q14207
NPATENST00000850623.1 linkc.4225T>G p.Ser1409Ala missense_variant Exon 18 of 18 ENSP00000520908.1
NPATENST00000530859.1 linkn.1598T>G non_coding_transcript_exon_variant Exon 5 of 5 2
NPATENST00000530926.1 linkn.382T>G non_coding_transcript_exon_variant Exon 2 of 2 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1454872
Hom.:
0
Cov.:
27
AF XY:
0.00000138
AC XY:
1
AN XY:
724222
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33380
American (AMR)
AF:
0.00
AC:
0
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26084
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39510
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86144
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50100
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5736
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1109000
Other (OTH)
AF:
0.00
AC:
0
AN:
60224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 12, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.S1409A variant (also known as c.4225T>G), located in coding exon 18 of the NPAT gene, results from a T to G substitution at nucleotide position 4225. The serine at codon 1409 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.062
T
Eigen
Benign
-0.11
Eigen_PC
Benign
0.027
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.47
T
M_CAP
Benign
0.0068
T
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.63
N
PhyloP100
3.6
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.049
Sift
Benign
0.15
T
Sift4G
Benign
0.47
T
Polyphen
0.21
B
Vest4
0.090
MutPred
0.13
Loss of phosphorylation at S1409 (P = 0.0089);
MVP
0.29
MPC
0.055
ClinPred
0.60
D
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.056
gMVP
0.035
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr11-108029728; API